We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+3.61%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$22B
AUM Growth
-$123M
(-0.55%)
Cap. Flow
-$1.19B
Cap. Flow
% of AUM
-5.42%
Top 10 Holdings %
Top 10 Hldgs %
11.79%
Holding
1,359
New
101
Increased
421
Reduced
517
Closed
125
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$62M |
| 2 |
UBS Group
UBS
|
+$49.7M |
| 3 |
Air Products & Chemicals
APD
|
+$47.3M |
| 4 |
AT&T
T
|
+$44.6M |
| 5 |
Lam Research
LRCX
|
+$39.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hewlett Packard
HPE
|
+$61.6M |
| 2 |
HCA Healthcare
HCA
|
+$50.8M |
| 3 |
Gen Digital
GEN
|
+$50.7M |
| 4 |
Baxter International
BAX
|
+$50.6M |
| 5 |
Johnson & Johnson
JNJ
|
+$49.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.71% |
| 2 | Healthcare | 16.86% |
| 3 | Financials | 11.57% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Industrials | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Crown Castle
CCI
$31.2B
| $6.22M | 0.03% |
62,095
+990
| +2% | +$97.3K |
|
|
CSGS
527
DELISTED
CSG Systems International
CSGS
| $6.19M | 0.03% |
152,600
+21,900
| +17% | +$859K |
|
528
Harley-Davidson
HOG
$2.87B
| $6.19M | 0.03% |
114,600
+90,000
| +366% | +$5.01M |
|
529
Mohawk Industries
MHK
$8.74B
| $6.19M | 0.03% |
25,613
+11,904
| +87% | +$2.81M |
|
|
DERM
530
DELISTED
Dermira, Inc.
DERM
| $6.18M | 0.03% |
212,254
| – | – |
|
|
FL
531
DELISTED
Foot Locker
FL
| $6.14M | 0.03% |
124,624
+61,824
| +98% | +$4.01M |
|
532
Sunstone Hotel Investors
SHO
$2.05B
| $6.14M | 0.03% |
380,854
+236,100
| +163% | +$3.72M |
|
|
BIG
533
DELISTED
Big Lots, Inc.
BIG
| $6.06M | 0.03% |
125,500
-2,000
| -2% | -$97.3K |
|
534
ScottsMiracle-Gro
SMG
$3.27B
| $6.05M | 0.03% |
+67,600
| New | +$6.09M |
|
|
BLUE
535
DELISTED
bluebird bio
BLUE
| $6.04M | 0.03% |
4,435
-5,127
| -54% | -$6.19M |
|
536
ICICI Bank
IBN
$102B
| $5.94M | 0.03% |
662,036
+302,003
| +84% | +$2.55M |
|
537
Coherus Oncology
CHRS
$205M
| $5.94M | 0.03% |
413,728
+44,976
| +12% | +$865K |
|
538
Oceaneering
OII
$4.75B
| $5.89M | 0.03% |
258,000
-18,800
| -7% | -$478K |
|
539
Cheesecake Factory
CAKE
$4.81B
| $5.89M | 0.03% |
117,100
+94,305
| +414% | +$5.57M |
|
|
EQC
540
DELISTED
Equity Commonwealth
EQC
| $5.87M | 0.03% |
185,637
-97,000
| -34% | -$3.07M |
|
541
Brinker International
EAT
$8.5B
| $5.86M | 0.03% |
153,760
-4,600
| -3% | -$191K |
|
|
DRE
542
DELISTED
Duke Realty Corp.
DRE
| $5.84M | 0.03% |
+209,064
| New | +$5.88M |
|
|
DGL
543
DELISTED
Invesco DB Gold Fund
DGL
| $5.8M | 0.03% |
146,345
-37,725
| -20% | -$1.52M |
|
|
STML
544
DELISTED
Stemline Therapeutics, Inc.
STML
| $5.79M | 0.03% |
629,205
+195,022
| +45% | +$1.63M |
|
545
Teck Resources
TECK
$31.7B
| $5.78M | 0.03% |
333,346
-70,720
| -18% | -$1.35M |
|
546
New Oriental
EDU
$8.95B
| $5.77M | 0.03% |
81,896
+14,650
| +22% | +$1.01M |
|
547
RLJ Lodging Trust
RLJ
$1.67B
| $5.76M | 0.03% |
289,721
+4,000
| +1% | +$85.7K |
|
|
WCN
548
Waste Connections
WCN
$40.1B
| $5.69M | 0.03% |
+88,367
| New | +$5.49M |
|
549
Ameren
AEE
$28.5B
| $5.62M | 0.03% |
102,813
+88,300
| +608% | +$4.9M |
|
550
Amkor Technology
AMKR
$11.5B
| $5.57M | 0.03% |
570,480
-5,400
| -0.9% | -$61.1K |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q2 2017 Portfolio in Review
As of Q2 2017, Axa held 1,359 positions worth $22B, down 0.55% from $22.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Axa withdrew a net $1.19B in Q2 2017, closing 125 positions and reducing 517 holdings. Its most notable exit was Mead Johnson Nutrition Company, an estimated $22.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in Element Solutions worth $22.3M.
- Axa's largest Q2 2017 buy was Element Solutions: 1,758,931 shares worth $22.3M.
- Axa added most to Micron Technology in Q2 2017, an estimated $62M increase.
- Axa's biggest Q2 2017 reduction was Hewlett Packard, cutting an estimated $61.6M.
- Axa fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $22.7M.
- Axa's ten largest holdings make up 12% of its $22B portfolio in Q2 2017.
- Axa opened 101 new positions and closed 125 in Q2 2017.
- Axa's portfolio value fell 0.55% quarter-over-quarter to $22B.
Based on Axa's 13F filing for Q2 2017, filed 10 Aug 2017.